Brief: BriaCell Announces $4 Million Strategic Investment And Clinical Alliance With Prevail Partners, LLC And Prevail Infoworks, Inc.
15/05/2023 13:11
May 15 (Reuters) - Briacell Therapeutics Corp BCT.TO :
* BRIACELL ANNOUNCES $4 MILLION STRATEGIC INVESTMENT AND
CLINICAL
ALLIANCE WITH PREVAIL PARTNERS, LLC AND PREVAIL INFOWORKS, INC.
Source text for Eikon: ID:nGNX1XYy5m
Further company coverage: BCT.TO
((Reuters.Brief@thomsonreuters.com;))
Recent news on Briacell Therapeutics
See all newsBrief: Briacell Therapeutics Prices 1.45 Million Common Shares At $3.25 Per Share
Brief: Briacell Receives Positive Recommendation From Data Safety Monitoring Board (Dsmb) For Phase 3 Study In Metastatic Breast Cancer
Brief: Briacell Expands Pipeline To Include An Ovarian Cancer Immunotherapy Candidate, Bria-Ova+™
Brief: Briacell Phase 3 Bria-Imt™ Study Enrollment Surpasses 230 Patients
Brief: Briacell Adds Nyu Langone Health’S Perlmutter Cancer Center As Clinical Site In Pivotal Phase 3 Breast Cancer Study